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Nuclear Access and Action of Notch In Vivo
transduction remains controversial.On the positive side,Gary Struhl* and Atsuko Adachi
Howard Hughes Medical Institute Notch cleavage products that include portions of the
Notch intracellular domain have been identified in tissueDepartment of Genetics and Development
Columbia University College of Physicians culture cells and in whole animal extracts (e.g., Aster et
al., 1994; Kopan et al., 1996; Blaumueller et al., 1997).and Surgeons
New York, New York 10032 Moreover, portions of the Notch intracellular domain
have been shown to associate physically with the Sup-
pressor of Hairless (Su[H]) protein, a sequence-specific
DNA-binding protein, which appears responsible for ac-Summary
tivating the transcription of downstream target genes in
response to Notch receptor activity (reviewed in Honjo,The Drosophila Notch (N) gene encodes a conserved
1996; Weinmaster, 1997).single-pass transmembrane receptor that transduces
On the negative side, all attempts to obtain direct evi-extracellular signals controlling cell fate. Here, we pre-
dence for ligand-dependent nuclear access of the Notchsent evidence that the intracellular domain of Notch
intracellular domain have failed, despite the existencegains access to the nucleus in response to ligand,
of antisera specific for epitopes within the intracellularpossibly through a mechanism involving proteolytic
domain and the ability to examine altered forms of Notchcleavage and release from the remainder of the pro-
(e.g., lacking portions of the extracellular domain includ-tein. In addition, our results suggest that signal trans-
ing the LNRs) that have constitutive transducing activityduction by Notch depends on the ability of the intracel-
(Fehon et al., 1991; Lieber etal., 1993; Rebay et al., 1993).lular domain, particularly the portion containing the
Also, there is no direct evidence that the productiveCDC10 repeats, to reach the nucleus and to participate
interaction between Notch and Su(H) occurs within thein the transcriptional activation of downstream target
nucleus. Indeed, analyses of the physical relationshipsgenes.
between Notch and Su(H) protein in tissue culture and
in vivo have led to proposals in which Notch tethersIntroduction
Su(H) at the cell surface, releasing and perhaps modi-
fying Su(H) in response to ligand (Fortini and Artavanis-Notch belongs to a conserved family of transmembrane
Tsakonas, 1994; Lecourtois and Schweisguth, 1995; Ko-receptors that transduce intercellular signals controlling
pan et al., 1996; Roehl et al., 1996).cell fate (reviewed in Weinmaster, 1997; Greenwald,
Here,we describe experimentsdesigned to test whether1998). All of the members of this family are single-pass
the Notch intracellular domain normally gains access totransmembrane proteins that respond to ligands of the
the nucleus in response to ligand and whether it actsDelta-Serrate-Lag2 (DSL) family and contain several
within the nucleus to regulate the transcription of down-conserved sequence motifs. The large extracellular do-
stream target genes. Our results provide evidence thatmain contains many tandem repeats of an epidermal
such access occurs, possibly by a mechanism involvinggrowth factor (EGF) motif as well as three copies of a
proteolytic cleavage that leads to the release of theªLin-12/N repeatº (LNR). In addition, they contain intra-
intracellular domain from the rest of the protein. In addi-cellular domains that include a block of six CDC10 (or
tion, they support the hypothesis that the intracellularankyrin) repeats, one or two nuclear localization signals
domain of Notch, and particularly the CDC10 repeats,(NLS), a homopolymer repeat of glutamine (an ªOPAº
transduce Notch signals by acting within the nucleus todomain), and a proline-glutamate-serine-threonine±rich
activate gene transcription.ªPESTº domain. However, the intracellular domains of
Notch proteins lack any recognizable catalytic motif,
and it remains unclear how they transduce extracellular Results
signals.
Truncated forms of Notch that consist of only the Evidence for Nuclear Access of the Notch
intracellular domain have constitutive transducing activ- Intracellular Domain in Vivo
ity (Lieber et al., 1993; Struhl et al., 1993) and localize As noted in the Introduction, attempts to detect the
predominantly in the nucleus (Fortini et al., 1993; Lieber physical presence of intracellular portions of Notch in
et al., 1993; Struhl et al., 1993; Kopan et al., 1994). Hence, the nucleus by conventional immunological or biochemi-
it has been proposed that interactions between ligand cal means have generally been unsuccessful, even in
and theextracellular domain of Notch induce the release cells in which the receptor is active. We have therefore
of the intracellular domain from the membrane and that employed a potentially more sensitive approach in which
the intracellular domain translocates to the nucleus, the chimeric transcription factor Gal4-VP16 (GV) is in-
where it transduces N signals by regulating the tran- serted at various positions in otherwise wild-type Notch
scription of downstream target genes (Lieber et al., protein (Figure 1) and the resulting N1-GV proteins ex-
1993; Struhl et al., 1993; Kopan et al., 1994). pressed under heat shock control in embryos that also
The possibility of such a direct mechanism of signal carry a UAS-lacZ transgene (Experimental Procedures).
The Gal4-VP16 protein contains the DNA-binding do-
main of the yeast Gal4 transcription factor coupled to*To whom correspondence should be addressed.
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the transcriptional activating domain of the viral VP16
protein (Sadowski et al., 1988). The UAS-lacZ gene con-
tains four copies of the UAS-binding site for Gal4 and
is transcribed in response to Gal4 as well as the Gal4-
VP16 protein in Drosophila melanogaster (Fischer et al.,
1988; data not shown). We reasoned that expression of
the UAS-lacZ gene would provide a sensitive assay for
nuclear access of the inserted Gal4-VP16 domain and
hence for events that lead to nuclear import of the Notch
intracellular domain.
The Gal4-VP16 coding sequence was inserted at ei-
ther of two positions in the intracellular domain: just
carboxy-terminal to the transmembrane domain to gen-
erate the chimeric protein N1-GV3 and after the domain
containing the CDC10 repeats to generate the chimeric
protein N1-GV4 (Figure 1). Heat shock±induced expres-
sion of each of these proteins during embryogenesis
caused expression of the UAS-lacZ gene in the ventral
ectoderm and the developing central nervous system,
as well as in other tissues (Figures 2 and 6; data not
shown). Cells in each tissue appeared to respond in a
salt and pepper fashion similar to that caused by low
level expression of the Gal4-VP16 protein alone (data
not shown). Our initial assays were performed using a
severe heat shock (378C for 1 hr, followed by a 2 hr
recovery), which generates levels of N1-GV protein that
are similar to that of endogenous Notch (data not
shown). However, mild heat shock (e.g., 338C for 60
min, followed by a 2 hr recovery) resulted in detectable
expression of the UAS-lacZ gene, even though the level
of N1-GV protein is severalfold lower than the level of
endogenous Notch (data not shown). We have examined
the subcellular localization of the Gal4 DNA-binding do-
main inserted in both proteins, as well as in all of the
remaining Gal4 derivatives shown in Figures 1 and 4, in
the embryonic ectoderm. In all cases, the Gal4 DNA-
binding domain appears to be localized predominantly
at the cell periphery (data not shown), as is the case
for both extracellular and intracellular epitopes of the
endogenous Notch protein (Fehon et al., 1991).
We also assayed the ability of these chimeric proteins
to provide Notch transducing activity. Specifically, we
have asked whether their expression can suffice to res-
Figure 1. Summary of Experiments Assaying Nuclear Access and cue formation of the ventral epidermis in N2 embryos
Transducing Activity of Notch inwhich all cellsof the ventral ectodermwould otherwise
The general structural features of Notch are diagrammed in the top develop as neuroblasts. To facilitate the analysis, we
panel with the EGF repeats, Lin12/Notch repeats (LNR), transmem-
used arm2 N2 embryos: when Notch function is restoredbrane domain (TM), NLSs, CDC10 repeats, OPA repeats, and PEST
in such embryos, they secrete a ventral cuticle that dis-sequences indicated. The Gal4-VP16 domain was inserted at four
plays the Armadillo segmentation phenotype allowingsites (arrows) and the resulting N1-GV proteins designated by the
insertion site (1±4; 0 5 no Gal4-VP16 insertion; 1\2 5 an insertion them to be identified unambiguously (Lieber et al., 1993;
of Gal4-VP16 in place of the domain normally positioned between Figure 5). For both the N1-GV3 and N1-GV4 proteins,
sites 1 and 2). The NECN, NSev11, and NEGF derivatives of these proteins we observed rescue (data not shown).
are diagrammed in the panels underneath (details of these con-
To test whether nuclear access of the inserted Gal4-structs are given in Table 1; note that the NSev11 derivative is com-
VP16 domain depends on its being located within theposed of the extracellular and transmembrane domains of the Sev11
intracellular domain, we assayed the activities of theprotein [hatched and black, respectively] joined to the intracellular
domain of Notch). All of the derivatives shown were tested for nu-
clear access of the inserted Gal4-VP16 domain by assaying their
ability to activate transcription of a UAS-lacZ target gene. In addi-
tion, all were tested for their ability to activate the Notch transduction ment in DlX43 hh10E embryos. The assays used (see Experimental Pro-
pathway by assaying whether they could rescue epidermal develop- cedures) generally yielded qualitatively distinct results as illustrated
ment in NXK11 armYD35 embryos. Finally, selected derivatives were in Figures 2, 5, and 6, except for UAS-lacZ expression activated
tested for ligand-dependent nuclear access and Notch transducing by N1-GV3 protein in Dl2 embryos. In this case, rare UAS-lacZ±
activity by assaying their ability to activate UAS-lacZ expression in expressing cells were observed (Figure 2) and the result indicated
Dl2 versus hsp70-Dl Dl2 embryos and to rescue epidermal develop- as ª(2)º rather than ª2º.
Nuclear Access and Action of Notch In Vivo
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Figure 2. Ligand Dependence of Notch Nu-
clear Access
Embryos carrying the UAS-lacZ reporter
gene and expressing the wild-type, ECN,
Sev11, and EGF derivatives of N-GV3 and
N-GV4 protein (Figure 1) are shown stained
for b-gal protein expression. For the N-GV3
derivatives, only the wild-type and ECN forms
induce b-gal expression. Moreover, the wild-
type form does so in a ligand-dependent
fashion, as indicated by the relative absence
of b-gal expression in Dl2 embryos compared
to Dl1 embryos and to Dl2 embryos supple-
mented with ectopic Delta expressed under
heat shock control (the few cells that express
b-gal in Dl2 embryos may reflect a response
of the N1-GV3 protein to another ligand, pos-
sibly Ser). In contrast, the ECN form induces
similar amounts of b-gal expression in Dl2
embryos compared to Dl1 embryos, indicat-
ing that it does so in a ligand-independent
fashion. For the N-GV4 derivatives, all induce
b-gal expression even in the absence of li-
gand (N1-GV4 in Dl2 embryos) or when por-
tions of the extracellular domain normally re-
quired for ligand-dependent activation of
Notch are deleted (NSev11-GV4 and NEGF-GV4).
However, the ability of N1-GV4 protein to in-
duce b-gal expression retains some depen-
dence on ligand (compare b-gal expression
in Dl2 with Dl2 hsDl embryos). Here, as in Fig-
ure 6, all embryos are staged around the end
of germband shortening, with anterior to the
left; similar results were obtained in embryos
staged as early as the completion of germ-
band extension and as late as the completion
of dorsal closure.
chimeric proteins N1-GV1 and N1-GV2, which contain find that expression of the N-GV1\2 chimeric protein can
rescue the formation of ventral epidermis not only in N2Gal4-VP16 insertions in either of two sites in the extra-
cellular domain, just before the LNR domain and just embryos but also in Dl2 embryos (Figure 1). Neverthe-
less, the N1-GV1\2 chimeric protein does not drive UAS-before the transmembrane domain (Figure 1). In contrast
to the results obtained with the N1-GV3 and N1-GV4 lacZ expression (Figure 1). We conclude that the Gal4-
VP16 domain present in the N1-GV1\2 protein does notproteins, no UAS-lacZ expression was observed in em-
bryos expressing N1-GV1 or N1-GV2 protein (data not have access to the nucleus, even though the chimeric
receptor is constitutively active.shown). However, neither the N1-GV1 nor the N1-GV2
protein was able to restore epidermal development in Thus, Gal4-VP16 insertions within the Notch intracel-
lular domain, both amino-terminal and carboxy-terminalarm2 N2 embryos (Figure 1), indicating that the chimeric
protein cannot function normally to transduce Notch to the CDC10 domain, appear to have access to the
nucleus in vivo, in contrast to Gal4-VP16 insertions insignals. We therefore expressed another chimeric pro-
tein, N1-GV1\2, in which the Gal4-VP16 coding se- the extracellular domain, which do not. In principle, this
access could be afforded by translocation of the entirequence was inserted in place of the LNR domain. As
previously shown, deletion of the LNR domain renders receptor from the membrane to the nucleus. Alterna-
tively, access may be afforded by one or more cleavageNotch constitutively active (Lieber et al., 1993), and we
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events that occur amino-terminal to the inserted Gal4- To test whether the Notch transducing activities of
the N1-GV3 and NECN-GV3 proteins are Delta-dependent,VP16 domain and allow release and nuclear import of
carboxy-terminal portions of the protein. we asked whether heat shock±induced expression of
either protein can rescue epidermal differentiation in Dl2
embryos (for these experiments, the Dl2 mutation was
Evidence for Ligand-Dependent Nuclear linked with a hh2 mutation so that rescued embryos
Access of Notch could be unambiguously identified by the Hedgehog
We have performed two sets of experiments to deter- segmentation phenotype; see Experimental Procedures).
mine whether nuclear access of the Gal4-VP16 domain We find that expression of the N1-GV3 protein fails to
in N1-GV3 protein depends on ligand. rescue epidermal differentiation in Dl2 hh2 embryos, in
In the first set of experiments, we have assayed UAS- contrast to expression of the NECN-GV3 protein, which
lacZ expression in embryos expressing a series of does (Figure 1; data not shown). Consequently the trans-
N-GV3 proteins that have alterations of the extracellular ducing activity of N1-GV3 protein, but not NECN-GV3 pro-
domain, which block their ability to respond to ligand tein, appears to be ligand-dependent.
or which render them constitutively active irrespective Thus, both sets of experiments provide evidence that
of ligand (Figure 1). One derivative, referred to as NECN- nuclear access of the Notch intracellular domain, as
GV3, lacks virtually all of the extracellular domain, in- assayed by ability of the Gal4-VP16 domain of N-GV3
cluding all 36 EGF repeats and the LNR domain. NECN proteins to activate UAS-lacZ expression, depends on
protein has previously been shown to have ectopic ligand and correlates with Notch transducing activity.
transducing activity, suggesting that it is constitutively
active irrespective of ligand (Fortini et al., 1993; Rebay
Evidence for Nuclear Access of Notchet al., 1993). A second, referred to as NEGF-GV3, consists
in the Absence of Ligandof a deletion of EGF repeats 4-26: like other forms of
We also analyzed nuclear access of the Gal4-VP16 do-Notch that have internal deletions of the EGF region
main in N-GV4 proteins, using the same tests for ligand(Lieber et al., 1993; Rebay et al., 1993), NEGF protein
dependence employed for the N-GV3 proteins. As showncannot rescue the absence of endogenous Notch activ-
in Figure 2, the main result we have obtained is thatity (Figure 1), indicating that it is unable to respond to
nuclear access of this domain, which is inserted car-ligand. The third, referred to as NSev11-GV3, lacks the
boxy-terminal to the CDC10 repeats, appears to dependentire extracellular domain as well as the transmem-
on both ligand-dependent and ligand-independent mech-brane domain of Notch and has in its place the extracel-
anisms. For example, the NSev11-GV4 and NEGF-GV4 pro-lular and transmembrane domains of Sev11, a truncated
teins can activate UAS-lacZ expression, even thoughform of the receptor tyrosine kinase Sevenless (Basler
they should not be able to respond to ligand. Similarly,et al., 1991). Like NEGF protein, NSev11 protein also appears
the N1-GV4 protein can activate the UAS-lacZ gene inunable to transduce ligand (Figure 1).
many cells in Dl2 embryos, despite the absence of DeltaThe main result we have obtained is that the N1-GV3
protein. Both sets of results indicate that carboxy-termi-and NECN-GV3 proteins can activate UAS-lacZ transcrip-
nal portions of the Notch intracellular domain that in-tion and, in addition, can provide Notch transducing
clude the GV4 insertion have access to the nucleus evenactivity to otherwise N2 embryos. In contrast, the NEGF-
in the absence of normal ligand stimuation. However,GV3 and NSev11-GV3 proteins can do neither (Figures 1
we also find evidence that ligand stimulates nuclearand 2). Thus, nuclear access of the Gal4-VP16 domain
access of the Gal4-VP16 domain in N1-GV4 protein.inserted in N-GV3 proteins correlates with Notch trans-
In particular, we consistently observe that more cellsducing activity: forms of N-GV3 protein that behave as
express the UAS-lacZ gene in heat-shocked hsp70-N1-if they cannot transduce Notch signals do not allow
GV4 Dl2 embryos when these embryos carry the hsp70-access, whereas forms that have ligand-dependent or
Dl transgene compared to when they do not.constitutive transducing activity do allow access.
Thus, at least some portions of the Notch intracellularIn the second set of experiments, we have assayed
domain appear to gain access to the nucleus in a ligand-whether nuclear access and Notch transducing activity
independent fashion, possibly as a consequence of pro-associated with the N1-GV3 and NECN-GV3 proteins de-
teolytic cleavages that occur carboxy-terminal to thepend on Delta (Dl), the primary ligand for activating
site of the GV3 insertion. We note that this ligand-inde-Notch in embryos (reviewed in Weinmaster, 1997; Green-
pendent access is not likely to be productive in termswald, 1998). To test whether nuclear access depends
of normal Notch signaling because wild-type Notch hason Delta, we compared the ability of the N1-GV3 and
no transducing activity in the absence of ligand, andNECN-GV3 proteins to activate UAS-lacZ expression in
both the NEGF and NSev11 proteins similarly lack transduc-heat-shocked Dl2 embryos versus heat-shocked Dl2
ing activity even in the presence of ligand (Figure 1; seeembryos in which Delta expression is restored by a
Discussion).hsp70-Dl transgene (see Experimental Procedures). For
the N1-GV3 protein, we find that only very few cellsshow
UAS-lacZ expression in the absence of Delta (Figure 2). Transducing Activity of the CDC10 Domain of
Notch Depends on Access to the NucleusHowever, in the presence of heat shock±induced Delta,
UAS-lacZ is widely expressed (Figure 2), indicating that The ability of Notch to transduce extracellular signals
depends critically on the integrity of the CDC10 repeatsthe response is ligand-dependent. By contrast, the
NECN-GV3 protein activates UAS-lacZ expression irre- within the intracellular domain (Greenwald and Seydoux,
1990; Kodoyianni et al., 1992; Lieber et al., 1993; Rebayspective of Delta (Figure 2).
Nuclear Access and Action of Notch In Vivo
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Figure 3. Predominant Subcellular Localization and Notch Transducing Activity of NCDC10 Proteins
The structures of Notch, Nintra, and the various derivatives of Flu-tagged NCDC10 proteins are diagrammed as in Figure 1 (the results for Notch
and Nintra have been published previously; Struhl et al., 1993). The top four NCDC10 derivatives are identical except for a single G→A substitution,
which inactivates the MYR signal in the MYR2 derivatives, and adjacent K→T substitutions, which inactivate the NLS signal in the NLS2
derivatives. The last derivative, NCDC10,Sev11MYR2NLS1 (bottom) is composed of the extacellular and transmembrane domains of the Sev11
protein fused immediately upstream of the NCDC10,MYR2NLS1 protein. All of the proteins shown were tested for Notch transducing activity by
examining whether they could rescue epidermal development in arm2 N2 embryos (assay 1), whether their expression could rescue epidermal
development in Dl2 hh2 embryos (assay 2), and whether their expression could suppress neuroblast segregations in early N1 embryos (assay
3). Wild-type Notch protein rescues the absence of the endogenous gene (1), but does not rescue the absence of Delta (2) or cause an anti-
neurogenic phenotype (3): it is scored as ª1º. In contrast, the remaining proteins either have all three activities (indicating that they have
intrinsic activity, scored as (ª↑º), or none of these activities (scored as ª2º). In addition, the predominant subcellular localization of each of
the NCDC10 derivatives was assayed using antisera against the CDC10 (in N2 embryos) and Flu epitopes. The ventral ectoderms of embryos
having clones of cells expressing each of the five forms of NCDC10 proteins are shown on the right stained for expression of the Flu epitope
(embryos are staged at the end of the early phase of germband extension). Note that the two derivatives that are found predominantly in the
nucleus have intrinsic Notch transducing activity, in contrast to two of the three derivatives that appear to be largely excluded from the
nucleus and lack detectable activity. The remaining derivative, NCDC10,MYR1NLS1, is exceptional in that it retains intrinsic transducing activity
even though it appears to be predominantly membrane associated. However, this protein differs from the NCDC10,MYR1NLS2 protein in that it
carries a wild-type rather than a mutant NLS sequence. We infer that the presence of the active NLS signal in this protein allows a small
amount to reach the nucleus despite the presence of the MYR1 signal, accounting for its intrinsic transducing activity.
et al., 1993), and in at least one case, a relatively small adjacent amino acids (Lys-Lys or Thr-Thr) within the
NLS.fragment of the intracellular domain that contains these
repeats has intrinsic transducing activity (Roehl and Each of the four proteins was expressed using a com-
bination of the Gal4/UAS (Fischer et al., 1988; Brand andKimble, 1993). We have therefore asked whether the
intrinsic transducing activity of such a fragment of Perrimon, 1993) and Flp-out (Basler and Struhl, 1994)
techniques to create embryos in which all, or only some,Notch, termed NCDC10, depends on whether it can gain
access to the nucleus. cells express the tagged protein (see Experimental
Methods) and the results of these experiments shownAs diagrammed in Figure 3, we have coupled a poly-
peptide containing the NCDC10 fragment and two copies in Figure 3. The MYR2NLS1 protein is localized predomi-
nantly in the nucleusand has intrinsic Notch transducingof the Flu-epitope tag (Wilson et al., 1984) with wild-type
or mutated versions of the myristylation signal (MYR) of activity, as indicated by its ability to block neuroblast
segregations inwild-type embryosand to rescueepider-Drosophila Src (Cross et al., 1984; Simon et al., 1985)
at the amino terminus and of a nuclear localization signal mal differentiation in arm2 N2 and in Dl2 hh2 embryos.
Similarly, MYR2NLS2 protein accumulates predomi-(NLS) from SV40 T antigen (Kalderon et al., 1984) at the
carboxy terminus to create four tagged forms of the nantly in the nucleus, despite the absence of an active
NLS, and has intrinsic signal-transducing activity. InCDC10 domain. In principle, these should be targeted
tomembranes (MYR1NLS2) or the nucleus (MYR2NLS1), contrast, the MYR1NLS2 protein appears to beexcluded
from the nucleus and lacks detectable Notch transduc-or to neither (MYR2NLS2) or both (MYR1NLS1). These
four proteins are identical except for changes in a single ing activity as it fails to rescue arm2 N2 embryos or
to block neuroblast segregations. In the case of theamino acid (Gly or Ala) within the MYR signal and in two
Cell
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MYR1NLS1 protein, most of the protein accumulates
outside of the nucleus, indicating that the MYR1 signal
predominates over the NLS1 signal. Nevertheless, this
protein retains Notch transducing activity, perhaps be-
cause the presence of an active NLS allows a small
amount to gain access to the nucleus despite the pres-
ence of an active MYR signal. To test this possibility,
we created a fifth chimeric protein in which the Sev11
extracellular and transmembrane domains were fused
immediately upstream of the MYR2NLS1 protein. The
resulting protein, Sev11MYR2NLS1, has a conventional
signal sequence at its amino terminus and should be
inserted into the membrane as it is synthesized. As a
consequence, it should remain stably membrane associ-
ated, despite the presence of an active NLS at its car-
boxy terminus. As expected, the Sev11MYR2NLS1 pro-
tein appears to beexcluded from the nucleus. Moreover,
it lacks detectable Notch transducing activity, in con-
trast to MYR1NLS1 protein.
Thus, a discrete CDC10-containing portion of the
Notch intracellular domain has intrinsic transducing ac-
tivity. However, this transducing activity appears to re-
quire that the protein has access to the nucleus, as
it is enhanced by nuclear targeting and abolished by
membrane targeting. Because the CDC10 repeats are
essential for signal transduction in the context of the
Figure 4. Summary of Experiments Providing Evidence for a Direct
wild-type protein, we interpret these results as evidence Involvement of the Notch Intracellular Domain in Transcriptional
that transduction by Notch normally requires access of Regulation
the CDC10 repeats to the nucleus. A series of N1-G4 derivatives that carry activator (VP16) or repressor
(enRep,WRPW) motifs, as well as appropriate control derivatives, are
diagrammed on the left, and the results of assays for nuclear accessEvidence for Transcriptional Regulation
and Notch transducing activity (see Figure 1; Experimental Proce-by the Notch Intracellular Domain
dures) are indicated on the right (see also Figures 5 and 6). G99One reason why Notch signal transduction may depend
refers to the presence of the first 99 amino acids of Gal4 protein,on nuclear access of the CDC10 domain is that this
which contain principally the DNA-binding domain. G147 refers to
domain is directly involved in regulating transcription in the presence of the first 147 amino acids of Gal4 protein; these
response to ligand. To test this possibility, we have additional amino acids are present in the Gal4-VP16 domain inserted
assayed the consequences of inserting protein domains in the N-GV proteins diagrammed in Figure 1.
that have well-characterized roles in mediating tran-
scriptional activation or repression into the intracellular
First, we tested whether heat shock±induced expres-domain of otherwise intact Notch. We reasoned that if
sion of either N1-G4 or N1-GV4 protein can suffice tothe Notch intracellular domain normally participates in
rescue the formation of ventral epidermis in Dl2 hh2transcriptional regulation, adding such activating or re-
embryos. We observe that expression of the N1-GV4pressing domains might have opposite effects on the
protein, but not N1-G4, has rescuing activity (Figures 4regulation of downstream target genes, yielding pheno-
and 5; data not shown). Second, we tested whethertypes corresponding to gain or loss of activity of the
the expression of either protein can block neuroblastNotch pathway.
segregations in embryos, an assay for constitutiveTo assay the effects of inserting an activator domain,
Notch transducing activity (Struhl et al., 1993). We findwe compared the consequences of expressing N1-GV4
that heat shock±induced expression of N1-GV4 proteinprotein, which contains the transcriptional activating do-
represses neuroblast segregations, both in wild-typemain of VP16, with those of expressing a control chime-
and Dl2 embryos (data not shown). In contrast, we couldric protein, N1-G4, which contains the Gal4DNA-binding
not detect an effect of heat shock±induced expressiondomain at the same site but lacks the VP16 activation
of N1-G4 protein on these segregations.domain (Figure 4). We find that both proteins have Notch
Further evidence that insertion of the VP16 activatortransducing activity, as indicated by their ability to res-
domain can cause constitutive activity of Notch comescue the neurogenic phenotype of arm2 N2 embryos (Fig-
from comparing the Notch transducing activities of theures 4 and 5; data not shown). Moreover, both also
NSev11, NSev11-GV3, and NSev11-GV4 proteins (Figure 1). Noneare capable of directing UAS-lacZ expression in similar
of these proteins should be able to respond to ligand,numbers of cells, although the level of expression is
owing to the substitution of the extracellular and trans-significantly lower in thecase of N1-G4 (Figures 4 and 6).
membrane domains of the Sev11 protein for those ofHowever, two lines of evidence indicate that the added
Notch. Nevertheless, the presence of the Gal4-VP16 do-presence of the VP16 domain in N1-GV4 protein renders
main inserted in NSev11-GV4 protein allows this proteinit constitutively active in terms of Notch signal transduc-
to rescue epidermal development in arm2 N2 embryos,tion, in contrast to N1-G4 protein, which lacks this do-
main and is ligand-dependent. correlating with the ability of the Gal4-VP16 domain to
Nuclear Access and Action of Notch In Vivo
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Figure 5. Rescue of Epidermal Differentiation in arm2 N2 and Dl2
hh2 Embryos by N1-G4 and N1-GV4 Proteins
In arm2 N2 and Dl2 hh2 embryos, virtually all ectodermal cells differ-
entiate as neural tissue at the expense of epidermis, leading to
absence of cuticular structures. However, epidermal differentiation
is restored in arm2 N2 embryos that express N1-G4 protein and in
Dl2 hh2 embryos that express N1-GV4 protein. The arm2 and hh2
mutations are linked, respectively, to the N2 and Dl2 mutations and
cause distinctive ªlawnª phenotypes of disorganized ventral hairs,
confirming the genotypes of the ªrescuedª embryos.
gain access to the nucleus even in theabsence of normal
ligand interactions (Figure 1). One interpretation of this
finding is that all three proteins are cleaved carboxy-
terminal to the Sev11 transmembrane domain, but only
intracellular cleavage products derived from the NSev11- Figure 6. Regulation of UAS-lacZ Expression by N1-G4 Proteins
GV4 protein include the VP16 activation and hence ac- Carrying Heterologous Transcriptional Activating or Repressing Do-
quire Notch transducing activity. Extending this intepre- mains
tation to the constitutive activity of N1-GV4 protein, we Embryos carrying the UAS-lacZ reporter gene and expressing the
various derivatives of N1-G4 protein diagrammed in Figure 4 aresuggest that addition of the VP16 activator domain con-
shown stained for b-gal protein expression. The presence of justfers transducing activity to intracellular cleavage prod-
the DNA-binding domain of Gal4 in N1-G4 protein leads to moderateucts of Notch that arise in the absence of ligand stimula-
levels of b-gal expression.The further addition of the VP16 activation
tion and would otherwise lack activity. We note that the domain enhances this level of expression, while the addition of the
added presence of the VP16 activation domain is not enRep or Hairy (WRPW) repression domains completely blocks this
sufficient to restore Notch transducing activity in the expression. By contrast, the WGPS and PEST derivatives of N1-G4
protein behave similarly to the canonical N1-G4 protein.case of NEGF-GV4 protein. Nevertheless, this protein can
activate UAS-lacZ expression, indicating that the Gal4-
VP16 domain does have access to the nucleus (Figures1 and mediates transcriptional repression at least in part
and 2). It is possible that NEGF proteins may be processed by recruiting the protein Groucho (Gro) (reviewed in
differently than NSev11 or N1 proteins, leading to intracel- Fisher and Caudy, 1998). In the first case, the enRep do-
lular cleavage products that lack Notch transducing ac- main was inserted in place of the VP16 domain in N1-
tivity even when coupled to a VP16 activating domain. GV4 protein to generate the protein N1-G4,enRep; in the
To assay the effects of inserting a repressor domain, second case, the WRPW peptide was added to the end
we used two different motifs: an alanine-rich portion of N1-G4 protein to create the protein N1-G4,WRPW
of the homeodomain protein Engrailed (enRep) and the (Figure 4). As controls for the N1-G4,WRPW experiment
WRPW tetrapeptide that is present at the C terminus of we also examined the consequences of adding a mu-
tated formof this peptide, WGPS (to generate theproteinbasic helix-loop-helix repressor proteins such as Hairy
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N1-G4,WGPS), or deleting the C-terminal 80amino acids Evidence for Ligand-Dependent Nuclear Access
of the Notch Intracellular Domainof Notch (to generate the protein N1-G4,PEST2). We
In the first series of experiments, we have used inser-find that both the N1-G4,enRep and N1-G4,WRPW pro-
tions of the Gal4-VP16 transcriptional activator at differ-teins lack detectable Notch signal±transducing activity,
ent sites within Notch protein to assay whether anyas indicated by their failure to rescue epidermaldevelop-
portions of the receptor normally have access to thement in arm2 N2 embryos (Figure 4; data not shown).
nucleus. The premise of this approach is that the Gal4-In addition, they are unable to activate expression of
VP16 domain must gain access to the nucleus to activatethe UAS-lacZ gene (Figures 4 and 6). In contrast, the
transcription of a UAS-lacZ target gene and henceN1-G4,WGPS and N1-G4,PEST2 proteins behave simi-
serves as an indicator for nuclear access of adjoininglarly to N1-G4: both have Notch signal±transducing ac-
Notch sequences. We have found that Gal4-VP16 do-tivity and can direct UAS-lacZ expression (Figures 4 and
mains inserted in the intracellular domain, but not the6; data not shown).
extracellular domain, of Notch do indeed have accessThus, adding well-defined transcriptional activating
to the nucleus, as judged by their ability to activate UAS-or repressing domains to intact Notch has opposing
lacZ transcription. Moreover, we show that access of aeffects on Notch signal transduction, causing gain or
specific Gal4-VP16 insertion, GV3, positioned just car-loss of activity, respectively. In a corresponding fashion,
boxy-terminal to the Notch transmembrane domain isthey also cause the enhancement or loss of UAS-lacZ
ligand-dependent and correlates with Notch signal±expression mediated by a Gal4 DNA-binding domain
transducing activity. Thus, our results provide in vivoinserted within Notch. We interpret these results as evi-
evidence that the intracellular domain of Notch gainsdence that Notch signal transduction normally involves
access to the nucleus in response to ligand stimulation.the direct participation of the intracellular domain in
activating the transcription of downstream target genes.
Evidence that Nuclear Access of the Intracellular
Domain Is Necessary for Signal Transduction
Discussion We performed a secondseries of experiments to investi-
gate whether nuclear access is required for Notch signal
Eukaryotic cells employ many strategies to link the re- transduction. We first defined a minimal fragment of
ception of extracellular signals to changes in gene ex- the Notch intracellular domain containing the CDC10
pression. In general, these strategies depend on trans- repeats that has intrinsic transducing activity (see also
membrane receptors, which receive signals at the cell Roehl and Kimble, 1993) and then asked whether the
surface and modify one or more intracellular effector intrinsic transducing activity associated with this frag-
proteins that transduce these signals to the nucleus. ment depends on its having access to the nucleus. We
The same mechanism may also apply for Notch signal find that addition of sequences that permit or target
transduction. In this case, interactions between ligand this polypeptide to accumulate in the nucleus retain
and Notch at the cell surface would modify an effector transducing activity, whereas sequences that target this
such as the DNA-binding protein Su(H), which then polypeptide to membranes block the activity. Because
translocates to the nucleus and regulates gene expres- the CDC10 repeats are essential for signal transduction
sion. However, the Notch intracellular domain contains by Notch (Greenwald and Seydoux, 1990; Kodoyianni
conserved nuclear localization signals and, when ex- et al., 1992; Lieber et al., 1993; Rebay et al., 1993), we
interpret these results as evidence that the Notch intra-pressed on its own, accumulates predominantly in the
cellular domain must normally reach the nucleus to trans-nucleus and has constitutive transducing activity. These
duce Notch signals.observations have suggested an alternative and unusual
mechanism for Notch signal transduction. In this case,
ligand binding to the extracellular domain of the receptor Evidence for a Direct Role of the Notch Intracellular
would induce translocation of the intracellular domain Domain in Transcriptional Activation
to the nucleus, where it acts, in association with Su(H) We performed a third set of experiments to examine the
or other DNA-binding proteins, to regulate transcription. role of the Notch intracellular domain in the nucleus and,
As outlined in the Introduction, all previous attempts specifically,whether it acts directly to regulate transcrip-
to obtain direct evidence for ligand-dependent nuclear tion. We inserted structural motifs that have well-defined
access of the Notch intracellular domain have failed. roles in transcriptional activation and repression into the
Hence, if Notch transduces extracellular signals through intracellular domain of intact Notch. We find that adding
a mechanism that depends on nuclear import of the the VP16 activator domain renders the protein constitu-
intracellular domain, one would have to argue that the tively active, provided that it is inserted at a position
amount of protein that accumulates in the nucleus is so which allows it to gain access to thenucleus irrespective
small that it cannot be readily detected by conventional of ligand. Moreover, the presence of the VP16 domain
biochemical or immunological means. Here, we have enhances the ability of Notch derivatives that carry the
used potentiallymore sensitive in vivoassays for nuclear Gal4 DNA-binding domain to activate transcription of
access and action to ask whether the Notch intracellular the UAS-lacZ target gene. In contrast, adding repressor
domain does indeed gain access to the nucleus in re- motifs from either Engrailed or Hairy blocks the signal-
sponse to ligand and whether it transduces Notch sig- transducing activity of the resulting Notch proteins as
nals within the nucleus by regulating the transcription well as their ability to activate UAS-lacZ expression via
the Gal4DNA-binding domain. These results support theof downstream target genes.
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hypothesis that the Notch intracellular domain directly protein appears to be cleaved in a region close to the
junction between the transmembrane and intracellulartransduces Notch signals within the nucleus by activat-
ing the transcription of downstream target genes. domains resulting in nuclear localization of at least some
of the cleaved protein in at least some cells (Kopan et
al., 1996). Although this cleavage has been assumed to
Possible Mechanisms for Ligand-Dependent occur within the intracellular domain (Kopan et al., 1996),
Nuclear Access of Notch the biochemical evidence is also compatible with a
In principle, interactions between ligand and the extra- cleavage event within the transmembrane domain.Thus,
cellular domain of Notch might allow the intracellular it is possible that both the mNDE and Drosophila NECN
domain to gain access to the nucleus by either of two proteins are constitutively active because they mimic
mechanisms. In the first, these interactions would in- an intermediate normally generated during ligand-depen-
duce translocation of the entire receptor from the mem- dent processing of the extracellular domain of Notch
brane to the nucleus. To be consistent with our findings, and are further processed, like endogenous Notch pro-
the translocated receptor would have to retain a mem- tein, by cleavages that occur within or just carboxy-
brane topology that would allow Gal4-VP16 domains terminal to the transmembrane domain.
inserted in the intracellular domain tobind and transcrip- Notch proteins also appear to be cleaved at a second
tionally activate UAS-lacZ target genes while precluding site in the extracellular domain as they mature and are
the same activity by Gal4-VP16 domains inserted in the exported to the cell surface to yield a disulfide bond±
extracellular domain. In the second mechanism, which linked heterodimer composed of a large amino-terminal
we favor, nuclear access would be afforded by one or portion of the extracellular domain and the remainder
more ligand-dependent proteolytic cleavages, which of the protein (Blaumueller et al., 1997). This cleavage
occur amino-terminal to the Notch intracellular domain appears to depend on the activity of a membrane-asso-
and lead to its ability to move from the membrane to ciated metalloprotease, Kuzbanian, which is required
the nucleus. for Notch signal transduction (Pan and Rubin, 1997).
A precedent for such a proteolytic processing mecha- However, there is no evidence at present that Kuzbanian
nism is provided by the sterol-dependent nuclear import actually cleaves Notch or is involved in ligand-depen-
of DNA-binding domains of the Sterol Regulatory Ele- dent processing of Notch.
ment Binding Proteins 1 and 2 (SREBP-1 and SREBP-2) We note that processing of b-amyloid precursor pro-
(reviewed in Brown and Goldstein, 1997). Each of the tein (b-APP) involves an intramembrane cleavage that
SREBPs is composed of three domains, an amino-termi- depends on the function of Presenilin proteins (De-
nal cytosolic domain that includes a transcription factor Strooper et al., 1998), which also appear to be required
of the basic-helix-loop-helix class, a central domain for normal Notch activity (reviewed in Greenwald, 1998).
consisting of two transmembrane domains flanking a Presenilins may therefore have a common role in facili-
short extracytosolic domain, and a carboxy-terminal cy- tating cleavages within or adjacent to the transmem-
tosolic domain. A reduction in cholesterol abundance brane domains of both Notch and b-APP proteins.
is sensed by the SREBP cleavage-activating protein Previous genetic studies of Lin-12 and Notch have
(SCAP), which mediates a sequence-specific cleavage suggested that ligand activates Notch proteins by facili-
event in the extracytosolic domain. This first cleavage tating oligomerization (Greenwald and Seydoux, 1990;
then precipitates a second cleavage, which occurs Heitzler and Simpson, 1993). If signal transduction by
within the amino-terminal transmembrane domain. As a Notch depends on ligand-dependent cleavages within
consequence of the second cleavage, the amino-termi- or amino-terminal to the transmembrane domain, it fol-
nal cytosolic domain is released from the membrane and lows that oligomerization may serve to regulate the pro-
translocates to the nucleus, where it binds cholesterol teolytic activity responsible for this cleavage. For exam-
response genes and activates their transcription. ple, oligomerization may allow the recruitment of an
We suggest that the Notch intracellular domain may extracellular or transmembrane protease. Alternatively,
gain access to the nucleus by a similar mechanism to such a protease may always be associated with Notch,
that of the SREBPs with ligand binding precipitating one but it requires oligomerization to act.
or more cleavages, leading to the release of the intra-
cellular domain from the membrane. Because the Gal4-
VP16 domain inserted just downstream of the trans- Nuclear Access of Carboxy-Terminal Portions
of the Notch Intracellular Domainmembrane domain of N1-GV3 protein gains access to
the nucleus in response to ligand, these cleavages in the Absence of Ligand
Our findings using N-GV4 proteins suggest that somewould presumably occur in the extracellular or trans-
membrane domains, as in the case of SREBPs, or just carboxy-terminal fragments of the Notch intracellular
domain gain access to the nucleus as a consequencecarboxy-terminal to the transmembrane, within or amino-
terminal to three basic amino acids that comprise a of cleavages within the intracellular domain. However,
in contrast to the ligand-dependent nuclear access weputative stop-transfer sequence.
The relationship of the proposed ligand-dependent detect using N-GV3 proteins, none of the carboxy-termi-
nal processing events suggested by our experimentscleavage(s) to other biochemically defined cleavages in
Notch proteins is uncertain. When expressed in mam- with N-GV4 proteins appear to depend on ligand. Nor do
they appear to correlate with Notch signal±transducingmalian tissue culture cells, a truncated derivative of
mouse Notch1 protein equivalent to Drosophila NECN activity, except in proteins in which the resulting car-
boxy-terminal portions of the intracellular domain wouldprotein, mNDE, has constitutive activity. Moreover, this
Cell
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Table 1. Amino Acid Sequences at Joins in Deleted or Chimeric Proteins





























Sev11MYR2 signal Sev11/MYR2 LVLVRK/rrsagrt/MANKCCSKRQ
a As indicated in Figures 1 and 4 and in text. For the N1-G4,PEST2, N1-G4,WRPW, and N1-G4,WGPS proteins, the G4 insertion is the same
as that shown for N1-G4 protein and is composed of the first 99 amino acids of the Gal4 protein. For the N1-G4,enRep protein, the G4 insertion
is composed of the first 147 amino acids of the Gal4 protein (all of the GV insertions contain the same 147 amino acid domain fused at the
carboxyl terminus of the VP16 activation [Sadowski et al., 1988]). For the NCDC10 series, all five proteins are identical to NCDC10,MYR1NLS1
except for the substitution of the mutated MYR or NLS signals, or the Sev11MYR2 signal. The Sev11 and NECN proteins are described,
respectively, in Basler et al. (1991) and Rebay et al. (1993).
b Six amino acids of each protein adjacent to the join are shown (N sequences are in boldface), and the joins are listed in the amino-terminal
to carboxyl-terminal order. The Flu, MYR, and NLS signals are shown in full. Linkers between the joins, when present, are indicated in lower
case.
also contain insertions of the VP16 activating domain. At proteins that associate physically with the Notch intra-
cellular domain, such as Su(H), Dishevelled, Deltex, andpresent, a minimalist view of these putative intracellular
cleavages is that they reflect nonspecific degradative Numb, as well as other proteins, such as Mastermind
and Hairless (reviewed in Weinmaster, 1997; Greenwald,events that do not normally play a role in signal transduc-
tion, except perhaps in the potentially important process 1998). Hence, interactions between ligand and the Notch
extracellular domain may be required not only to releaseof down-regulating receptor activity. However, it re-
mains possible that one or more of these processing the intracellular domain but also to initiate a series of
other events within the cell that are required to generateevents is essential for N signal±transducing activity once
a ligand-dependent cleavage occurs upstream. a productive complex of this domain with other proteins.
What is the nature of this complex, and what is its
role in the nucleus? At least in the embryonic ventralSignal Transduction by the Notch
ectoderm, our findings support the view that the NotchIntracellular Domain
intracellular domain functions in the nucleus to activateIn principle, the only limiting step in the mechanism of
transcription of downstream target genes. Key targetssignal transduction by Notch may be the proposed li-
for Notch-dependent transcriptional activation are genesgand-dependent cleavage event that releases the intra-
of the Enhancer of split complex (E[spl]). These genescellular domain from themembrane and allows it to enter
are required in the ventral ectoderm to specify epidermalthe nucleus. In favor of this view, the Notch intracellular
versus neural differentiation (reviewed in Weinmaster,domain has intrinsic signal-transducing activity and is
1997; Greenwald, 1998). Morever, they have been shownfound predominantly in the nucleus when expressed on
to be direct targets for binding by the Su(H) proteinits own (Lieber et al., 1993; Struhl et al., 1993). Moreover,
(Bailey and Posakony, 1995; Lecourtois and Schweis-the intrinsic activity of a smaller domain composed pri-
guth, 1995) and to be transcriptionally activated in re-marily of the CDC10 repeats depends on its being al-
sponse to Notch signaling (Jennings et al., 1994; Jarri-lowed to enter the nucleus (Figure 3). However, Notch
signal transduction also appears to depend on several ault et al., 1995; Kopan et al., 1996; Eastman et al., 1997).
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composed of the Tuba1 promoter, which is active in most or allBy analogy with EBVNA2, a viral coactivator protein that
cells (Basler and Struhl, 1994), positioned upstream of a Gal4-VP16interacts with a mammalian Su(H) homolog CBF1 to
coding sequence that contains the F442A mutation, which reducesconvert it from a transcriptional repressor to a transcrip-
the activity of the VP16 activation domain (Regier et al., 1993).
tional activator (Hsieh and Hayward, 1995), the Notch Epidermal rescue assay for N2 embryos: NXK11 armYD35/FM7 fe-
intracellular domain, perhaps in association with other males were crossed to males carrying a given hsp70-N or hsp70-
N-GV transgene and embryos subjected to three 1 hr 378C heatproteins, may combine with Su(H) to contribute an acti-
shocks interspersed with 3 hr recovery times at 258C. Larval cuticlesvation domain that allows Su(H) to activate the transcrip-
formed by the resulting embryos were assayed for the Armadillotion of E(spl) genes as well as other target genes. We
segmentation phenotype (Lieber et al., 1993). For the various Notchnote that Su(H) is not required for all Notch-dependent
derivatives that do not contain Gal4, the Gal4/UAS method was also
developmental decisions (Lecourtois and Schweisguth, used: for these experiments, NXK11 armYD35 embryos carrying a given
1995; Wang et al., 1997), raising the possibility that UAS-N gene and the Tuba1.Gal4-VP16F442A transgene were derived
from NXK11 armYD35/FM7 females. In all cases, identical results wereNotch mediates some cell fate choices by associating
obtained using the hsp70 promoter or the Gal4/UAS technique towith other DNA-binding transcription factors or by em-
express the same Notch protein.ploying other mechanisms to transduce extracellular
Epidermal rescue assay for Dl2 embryos: DlX43 hh10E/TM3 femalessignals.
were crossed to hsp70-N-GV/1; DlX43 hh10E/1 males, treated as
above for NXK11 armYD35 embryos, and the resulting cuticles scored
for the Hedgehog segmentation phenotype. For all of the NotchExperimental Procedures
derivatives that do not contain Gal4, equivalent experiments were
also performed using the Gal4/UAS method (as described aboveConstruction of Notch Transgenes
for epidermal rescue of N2 embryos) and identical results obtained.Wild-type and deleted derivatives of the N and N-GV coding se-
Assays for the subcellular distribution of Notch-derived proteins:quences were inserted into a Casper-hsp70 vector, which contains
a monoclonal antisera Mab179C6 (Fehon et al., 1991) was used tothe hsp70 promoter upstream of the insertion site and a 39 UTR
detect the intracellular domain of Notch. The epitope is present insequence from the SV40 T-antigengene downstream of the insertion
the CDC10 bearing domain used in the experiments shown in Figuresite. The N coding sequence was derived from a N minigene (as in
3. Commerically available polyclonal anti-Gal4 (Santa Cruz) andStruhl et al., 1993). The Gal4-VP16 coding sequence encodes the
monoclonal anti-Flu (BabCo) antisera were used to detect the Gal4first 147 amino acids of Gal4, including the DNA-binding domain,
and Flu epitopes. For the NCDC10,MYR NLS series of transgenes,and the carboxy-terminal 78 amino acids of VP16, including the
embryos carrying a hsp70-flp transgene, the 69B-Gal4 transgeneactivation domain (Sadowski et al., 1988). The Sev11 (Basler et al.,
(which drives the expression of UAS-target genes in most ectoder-1991), Myristylation (Cross et al., 1984; Simon et al., 1985), NLS
mal cells; Brand and Perrimon, 1993), and a given UAS.y1.(Kalderon et al., 1984), and Flu epitope (Wilson et al., 1984) se-
NCDC10,MYR NLS transgene were heat shocked to remove the .y1.quences have been described previously (Table 1). For some experi-
Flp-out cassette, generating clones of cells that express thements, we also used a pUAST vector (Brand and Perrimon, 1993)
NCDC10,MYR NLS coding sequence.to place N sequences under the control of a promoter that responds
to Gal4. In these contructs, a .y1. flp-out cassette (Basler and
Struhl, 1994) was introduced immediately upstream of the Notch
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UAS-lacZ Expression, and Notch Expression
UAS-lacZ expression: embryos carrying one copy of the given
hsp70-N-GV or hsp70-N-G transgene and one copy of the UAS-lacZ Received February 26, 1998; revised April 17, 1998.
reporter (Fischer et al., 1988) were heat shocked for 1 hr at 378C (or
lower temperatures, as indicated), allowed to recover for 2 hr at
References258C, and then fixed and stained for b-gal expression by standard
immunohistochemical methods (as in Struhl et al., 1993).
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